IBDEI0UB ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14952,0)
 ;;=788.20^^89^900^63
 ;;^UTILITY(U,$J,358.3,14952,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14952,1,4,0)
 ;;=4^788.20
 ;;^UTILITY(U,$J,358.3,14952,1,5,0)
 ;;=5^Urinary Retention
 ;;^UTILITY(U,$J,358.3,14952,2)
 ;;=^295812
 ;;^UTILITY(U,$J,358.3,14953,0)
 ;;=112.2^^89^900^66
 ;;^UTILITY(U,$J,358.3,14953,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14953,1,4,0)
 ;;=4^112.2
 ;;^UTILITY(U,$J,358.3,14953,1,5,0)
 ;;=5^Urogenital Candidiasis
 ;;^UTILITY(U,$J,358.3,14953,2)
 ;;=^266866
 ;;^UTILITY(U,$J,358.3,14954,0)
 ;;=600.01^^89^900^5
 ;;^UTILITY(U,$J,358.3,14954,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14954,1,4,0)
 ;;=4^600.01
 ;;^UTILITY(U,$J,358.3,14954,1,5,0)
 ;;=5^BPH with Obstruction
 ;;^UTILITY(U,$J,358.3,14954,2)
 ;;=^329933
 ;;^UTILITY(U,$J,358.3,14955,0)
 ;;=600.10^^89^900^40
 ;;^UTILITY(U,$J,358.3,14955,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14955,1,4,0)
 ;;=4^600.10
 ;;^UTILITY(U,$J,358.3,14955,1,5,0)
 ;;=5^Nod Prostate W/O UR Obst
 ;;^UTILITY(U,$J,358.3,14955,2)
 ;;=^329934
 ;;^UTILITY(U,$J,358.3,14956,0)
 ;;=585.9^^89^900^8
 ;;^UTILITY(U,$J,358.3,14956,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14956,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,14956,1,5,0)
 ;;=5^Chronic Renal Failure
 ;;^UTILITY(U,$J,358.3,14956,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,14957,0)
 ;;=788.64^^89^900^59
 ;;^UTILITY(U,$J,358.3,14957,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14957,1,4,0)
 ;;=4^788.64
 ;;^UTILITY(U,$J,358.3,14957,1,5,0)
 ;;=5^Urinary Hesitancy
 ;;^UTILITY(U,$J,358.3,14957,2)
 ;;=^334165
 ;;^UTILITY(U,$J,358.3,14958,0)
 ;;=788.65^^89^900^52
 ;;^UTILITY(U,$J,358.3,14958,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14958,1,4,0)
 ;;=4^788.65
 ;;^UTILITY(U,$J,358.3,14958,1,5,0)
 ;;=5^Straining of Urination
 ;;^UTILITY(U,$J,358.3,14958,2)
 ;;=^334166
 ;;^UTILITY(U,$J,358.3,14959,0)
 ;;=600.00^^89^900^4
 ;;^UTILITY(U,$J,358.3,14959,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14959,1,4,0)
 ;;=4^600.00
 ;;^UTILITY(U,$J,358.3,14959,1,5,0)
 ;;=5^BPH w/o Obstruction
 ;;^UTILITY(U,$J,358.3,14959,2)
 ;;=^334276
 ;;^UTILITY(U,$J,358.3,14960,0)
 ;;=599.70^^89^900^20
 ;;^UTILITY(U,$J,358.3,14960,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14960,1,4,0)
 ;;=4^599.70
 ;;^UTILITY(U,$J,358.3,14960,1,5,0)
 ;;=5^Hematuria
 ;;^UTILITY(U,$J,358.3,14960,2)
 ;;=^336751
 ;;^UTILITY(U,$J,358.3,14961,0)
 ;;=599.71^^89^900^21
 ;;^UTILITY(U,$J,358.3,14961,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14961,1,4,0)
 ;;=4^599.71
 ;;^UTILITY(U,$J,358.3,14961,1,5,0)
 ;;=5^Hematuria, Gross
 ;;^UTILITY(U,$J,358.3,14961,2)
 ;;=^336611
 ;;^UTILITY(U,$J,358.3,14962,0)
 ;;=599.72^^89^900^22
 ;;^UTILITY(U,$J,358.3,14962,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14962,1,4,0)
 ;;=4^599.72
 ;;^UTILITY(U,$J,358.3,14962,1,5,0)
 ;;=5^Hematuria, Microscopic
 ;;^UTILITY(U,$J,358.3,14962,2)
 ;;=^336612
 ;;^UTILITY(U,$J,358.3,14963,0)
 ;;=596.89^^89^900^12
 ;;^UTILITY(U,$J,358.3,14963,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14963,1,4,0)
 ;;=4^596.89
 ;;^UTILITY(U,$J,358.3,14963,1,5,0)
 ;;=5^Cystocele
 ;;^UTILITY(U,$J,358.3,14963,2)
 ;;=^87989
 ;;^UTILITY(U,$J,358.3,14964,0)
 ;;=596.81^^89^900^15
 ;;^UTILITY(U,$J,358.3,14964,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14964,1,4,0)
 ;;=4^596.81
 ;;^UTILITY(U,$J,358.3,14964,1,5,0)
 ;;=5^Cystostomy Infection
 ;;^UTILITY(U,$J,358.3,14964,2)
 ;;=^340556
 ;;^UTILITY(U,$J,358.3,14965,0)
 ;;=596.82^^89^900^13
 ;;^UTILITY(U,$J,358.3,14965,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14965,1,4,0)
 ;;=4^596.82
 ;;^UTILITY(U,$J,358.3,14965,1,5,0)
 ;;=5^Cystostomy Complication,Mechanical
